Detalhe da pesquisa
1.
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES).
Neurol Genet
; 8(6): e200034, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524101